However, when NAPQI exhausts the cellular glutathione pools, NAPQI will covalently bind to cellular proteins [2, 3] . For many years research focused on identifying cellular targets for NAPQI [4] and, although many protein adducts were identifi ed, none could readily explain cellular toxicity [5, 6] .
A more recently emerging concept is that the formation of protein adducts is a critical initiating signal that requires amplifi cation in order to cause cell death [6, 7] . Central to this amplifi cation concept of APAPinduced cell death is the mitochondria [6, 7] . Early studies showed that there is inhibition of mitochondrial respiration [8, 9] leading to cellular ATP depletion [10, 11] during APAP hepatotoxicity. Although some of the mitochondrial dysfunction is partially Cyclophilin D defi ciency protects against acetaminophen-induced oxidant stress and liver injury Introduction Acetaminophen (APAP) is currently one of the most widely consumed drugs in the world. Although safe when used at therapeutics doses, intentional or unintentional over-dosing can cause severe liver injury and even liver failure [1] . During the last decade APAP hepatotoxicity became the single most frequent cause of acute liver failure in the US and many other countries [1] . Early animal studies indicated that the toxicity is dependent on the metabolic activation of APAP by the cytochrome P450 system, which generates the reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI) [2] . NAPQI can be scavenged by glutathione; the majority of the glutathione adducts is eliminated as a mercapturic acid conjugate via urine [2] .
Correspondence: Hartmut Jaeschke, PhD, Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS 66160, USA. Tel: ϩ 1 913 588 7969. Fax: ϩ 1 913 588 7501. Email: hjaeschke@ kumc.edu reversible by supplying mitochondrial energy substrates [12] , NAPQI binding to mitochondrial proteins may also contribute to the mitochondrial damage [13, 14] . The amplifi cation of the original protein binding signal is caused by the formation of reactive oxygen species inside the mitochondria, as indicated by the selective increase of mitochondrial glutathione disulphide (GSSG) [10, 15] and the formation of peroxynitrite in the mitochondria [16] . This oxidant and nitrosative stress leads to damage of mitochondrial DNA [16] and release of inter-membrane proteins including cytochrome c , second mitochondria activator of caspases (Smac), endonuclease G and apoptosis-inducing factor (AIF) [7,17 -21] . Although declining ATP levels may prevent induction of caspase activation and apoptosis by the released cytochrome c [22, 23] , endonuclease G and AIF translocate to the nucleus and are involved in nuclear DNA fragmentation [20] . Interestingly, the initial release of the mitochondrial intermembrane proteins is facilitated by formation of bax pores in the outer membrane [21] . However, at later times, the effect is independent of bax and most likely related to mitochondrial damage due to the continued oxidant stress and peroxynitrite formation [21] .
The formation of the mitochondrial permeability transition pore (MPT) is a critical event in cell death [24] . The MPT is thought to involve proteins such as the voltage-dependent anion channel (VDAC) from the outer membrane, adenine nucleotide translocator from the inner membrane, cyclophilin D (CypD) from the matrix and other proteins such as peripheral benzodiazepine receptor, hexokinase and creatine kinase [24] . Although the role of VDAC in the MPT has been questioned [25] , the fact that cyclophilin D-defi cient cells are protected against necrotic cell death suggests that this protein is essential for the MPT pore [26] . However, it has been postulated that under conditions of severe stress, unregulated MPT pores may be formed by clustering of misfolded proteins [27] . Cyclosporine A, which can inhibit the MPT pore formation by binding to cyclophilin D, was shown to protect against APAP hepatotoxicity in vivo , suggesting a critical role of the MPT in the pathophysiology [28, 29] . However, APAP-induced cell death in cultured hepatocytes appears to involve the regulated, cyclosporine A-dependent MPT and the unregulated MPT [30] . Because pharmacological interventions may have offtarget effects, the main goal of this investigation was to evaluate the role of cyclophilin D in APAP-induced oxidant stress and cell death using a mouse model with genetic defi ciency of cyclophilin D.
Materials and methods

Animals
Male cyclophilin D-defi cient mice ( Ppif -/-mice), which are on a B6129SF2/J background, and their age-matched control littermates (B6129SF2/J) with an average weight of 18 -20 g were used in this study [26] . All animals were housed in an environmentally controlled room with 12 h light/dark cycle and allowed free access to food and water. The experimental protocols were approved by the Institutional Animal Care and Use Committees of the University of Kansas Medical Center and University of Missouri at Columbia and followed the criteria of the National Research Council for the care and use of laboratory animals in research. All chemicals were purchased from Sigma Chemical Co. (St Louis, MO) unless stated otherwise.
Experimental design
Mice were injected intraperitoneally with 200 mg/kg APAP (dissolved in warm saline) after overnight fasting. The animals were killed 30 min or 6 h after APAP treatment and blood was withdrawn from the vena cava into a heparinized syringe for measurement of alanine aminotransferase (ALT) activities (Kinetic Test Kit 68-B, Biotron Diagnostics, Inc., Hernet, CA). The liver was removed and was rinsed in saline; liver sections were fi xed in 10% phosphatebuffered formalin for histological analyses. The remaining liver was snap-frozen in liquid nitrogen and stored at − 80 ° C for measurement of glutathione (GSH) and glutathione disulphide (GSSG) as described [31, 32] .
Histology and immunohistochemistry
Formalin-fi xed tissue samples were embedded in paraffi n and 4 μ m sections were cut. Replicate sections were stained with haematoxylin and eosin (H&E) for evaluation of necrosis [23] . Sections were also stained for nitrotyrosine (NT) protein adducts with the DAKO LSAB peroxidase Kit (K684) (DAKO Corp., Carpinteria, CA) and an anti-nitrotyrosine antibody (Molecular Probes, Eugene, OR) [31] . For the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) assay, sections of liver were stained with the In Situ Cell Death Detection Kit, AP (Roche Diagnostics, Indianapolis, IN), as described in the manufacturer ' s instructions [23] .
Western blotting and cytochrome P450 activity measurements
Western blotting was carried out as described in detail [33] using the following antibodies: a rabbit antiphospho-JNK polyclonal antibody (Cell Signaling Technology, Danvers, MA), a rabbit anti-JNK antibody (recognizes only JNK2) (Santa Cruz Biotechnology Inc., Santa Cruz, CA) and a rabbit anti-Cyp2E1 polyclonal antibody (Abcam, Cambridge, MA).
For determination of cytochrome P450 activity, the 20 000 ϫ g supernatant from liver homogenates were used in the 7-ethoxy-4-trifl uoromethylcoumarin (7EFC) deethylase assay as described [34, 35] . Briefl y, samples were incubated in 0.1 M phosphate buffer (pH 7.4) with 0.4 mg/ml albumin and 1 mM NADPH. The reaction was initiated by addition of 7EFC (50 μ M fi nal concentration) and the increase in fl uorescence with time was monitored on a fl uorescence plate reader with an excitation at 410 nm and emission at 510 nm.
Statistics
All results were expressed as mean Ϯ SE. Comparisons between multiple groups were performed with one-way ANOVA followed by a post-hoc Bonferroni test. If the data were not normally distributed, we used the Kruskal-Wallis Test (non-parametric ANOVA) followed by Dunn ' s Multiple Comparisons Test; p Ͻ 0.05 was considered signifi cant.
Results
Lack of cyclophilin D protects against acetaminopheninduced liver injury
To evaluate the potential role of CypD in APAP hepatotoxicity, a moderate overdose of 200 mg/kg was selected. At 6 h, APAP induced signifi cant liver injury as indicated by the increase in plasma ALT activities (Figure 1 ) and the development of centrilobular necrosis ( Figure 2A ). However, liver injury in CypDdefi cient mice treated with APAP was completely prevented (Figures 1 and 2A) . Previous studies demonstrated that nuclear DNA fragmentation as visualized by the TUNEL assay is a consequence of mitochondrial dysfunction [16] . Consistent with these fi ndings, a substantial number of TUNELpositive cells were observed in the centrilobular regions, which correlated well with the areas of necrosis ( Figure 2B ). Nuclear DNA fragmentation was also eliminated in CypD-defi cient mice ( Figure 2B ).
Acetaminophen-induced oxidative and nitrosative stress
Covalent modifi cation of mitochondrial proteins by NAPQI leads to mitochondrial oxidant stress and peroxynitrite formation [6] . Consistent with these observations, nitrotyrosine protein adducts as a footprint for peroxynitrite formation were detected in the centrilobular areas ( Figure 2C ). Although there was a trend to less nitrotyrosine staining in CypDdefi cient mice, nitrotyrosine adducts were still detectable ( Figure 2C ). In addition, previous studies documented the selective increase of GSSG levels and the GSSG-to-GSH ratio in mitochondria as an indicator of a mitochondrial oxidant stress [10, 15] . At 6 h after APAP injection, GSH levels completely recovered in WT animals ( Figure 3A) . However, the GSSG levels were increased 6-fold over baseline ( Figure 3B ), resulting in an elevated GSSG-to-GSH ratio ( Figure 3C ). In CypD-defi cient animals, GSH levels were also fully recovered, but GSSG levels were only increased by 2.5-fold over baseline ( Figure 3B ). This caused a still signifi cantly elevated GSSGto-GSH ratio ( Figure 3C ). Thus, CypD-defi ciency attenuated but not eliminated formation of reactive oxygen species and peroxynitrite during APAP hepatotoxicity.
Because APAP-induced oxidant stress can trigger activation of c-jun-N-terminal kinase (JNK), expression of JNK and its activated form P-JNK were evaluated by western blotting (Figures 4A and B) . In WT mice APAP treatment induced JNK activation, which was prevented in CypD-defi cient mice ( Figures 4A  and B) . These fi nding suggest that JNK activation occurs in response to the post-MPT amplifi cation of oxidant stress and cellular damage.
Drug metabolism capacity in CypD-defi cient mice
To determine if CypD-defi cient mice have adequate capacity to metabolize APAP, Cyp2E1 levels were evaluated by western blotting. Cyp2E1 protein levels in CypD-defi cient mice were moderately increased over controls and APAP-treated WT animals ( Figure 4C ). To confi rm this fi nding, P450-dependent O-deethylase activity was determined using the substrate 7-ethoxy-4-trifl uoromethylcoumarin ( Figure 4D ). This reaction can be catalysed by Cyp2E1 [34, 35] . Similar to the western blot, there was a higher enzyme activity in CypD-defi cient mice compared to controls and APAP-treated WT mice ( Figure 4D ). Together these data suggests that CypDdefi cient mice have an adequate capacity to metabolically activate APAP. To more directly assess NAPQI formation, the initial depletion of hepatic GSH levels was evaluated 30 min after APAP administration [10] . APAP overdose caused Ͼ 80% loss of liver GSH levels in livers of both WT and CypDdefi cient mice ( Figure 5A ), suggesting a similar capacity to generate NAPQI. In contrast to later time points (Figure 2) , there was a similar decline of GSSG levels ( Figure 5B ) and, therefore, there was no increase of the GSSG-to-GSH ratio in WT or CypD-defi cient mice ( Figure 5C ).
Discussion
Cyclophilin D and APAP-induced cell death
The objective of this investigation was to evaluate the role of cyclophilin D as a critical component of the MPT pore in APAP-induced liver cell injury. Our data demonstrate that liver injury observed in WT animals after a moderate overdose of APAP is completely prevented in CypD-defi cient mice.
Because it is well established that CypD is essential for Ca 2 ϩ -and oxidant stress-induced MPT pore formation in mitochondria [26] , our data suggest that the initial APAP-induced hepatocellular injury is dependent on the formation of the MPT pore. These fi ndings are consistent with previous reports where a protective effect of cyclosporine A against APAP toxicity was shown in vivo [28, 29] and in vitro [30] . However, cyclosporine A has additional effects beyond binding to CypD, e.g. inhibiting calcineurin [36] , which may impact the mechanism of APAP toxicity. The current fi ndings provide direct evidence for the importance of CypD in the cell death mechanism after APAP overdose.
Although the molecular composition of the MPT pore is still poorly defi ned, it is well established that CypD is a critical regulator of this pore [37] . Nevertheless, it was shown that excessive Ca 2 ϩ can trigger the MPT in mitochondria of CypD-defi cient mice [26] . This suggests that CypD is not part of the actual pore and that under more severe stress conditions an unregulated MPT pore independent of CypD may be formed [27, 37] . In fact, cyclosporine A in cultured hepatocytes substantially delayed but did not eliminate cell death after exposure to high (10 mM) doses the absence of CypD or potentially by differences in the capacity to produce the reactive metabolite NAPQI. The protein levels of Cyp2E1, which is the most critical cytochrome P450 enzyme for metabolic activation of APAP in vivo [39] , were similar if not slightly higher in CypD-defi cient mice compared to WT animals. In addition, the P450-dependent O-deethylase activity, which is catalysed at least in part by Cyp2E1 [34, 35] , was higher in CypDdefi cient mice compared to WT mice. Furthermore, the initial depletion of hepatic GSH levels, which is a direct measure of the actual NAPQI formation [10, 12] , showed no difference between WT and KO mice. Interestingly, there was no increase in GSSG levels or the GSSG-to-GSH ratio as an indicator of oxidant stress during this early metabolism phase. These observations confi rm previous fi ndings that the metabolism of APAP is not responsible for the oxidant stress [6] . Together these data suggest that CypD-defi cient mice have an adequate capacity to metabolically activate APAP and therefore the protective effect against APAP induced liver injury is unlikely caused by a lack of reactive metabolite formation.
Cyclophilin D and APAP-induced oxidant stress
Oxidant stress is a potent inducer of the MPT pore opening in mitochondria [24, 37] . APAP overdose triggers a mitochondrial oxidant stress and peroxynitrite formation as indicated by the selective increase of mitochondrial GSSG in vivo [10, 15] , selective nitrotyrosine protein adduct formation in mitochondria in vivo [16] and the increased Mitosox Red fl uorescence in cultured hepatocytes [38] . The oxidant stress is preceding cell death [40] and the MPT [30] and scavenging reactive oxygen and peroxynitrite caused a profound protection against APAP hepatotoxicity in vivo [31, 41] and in vitro [40] . Furthermore, preventing lysosomal iron translocation to the mitochondria prevented the MPT pore opening and cell death [42] . The current fi ndings support the concept of reactive oxygen and peroxynitrite formation during APAP hepatotoxicity and show that CypD defi ciency attenuates but not eliminates this oxidant stress. These results are consistent with the hypothesis that at least a part of the oxidant stress occurs upstream of the MPT and is able to trigger the pore opening. On the other hand, the signifi cant reduction of the oxidant stress in CypDdefi cient mice indicates that part of the oxidant stress is a consequence of the MPT. These observations are consistent with the concept that the opening of the MPT pore and collapse of the membrane potential may trigger a transient increase in reactive oxygen formation some of which may affect neighbouring mitochondria [43] . This effect could be responsible for the propagation of the injury within the cell.
Although both reactive oxygen species and peroxynitrite are produced in mitochondria during APAP Figure 3 . APAP-induced oxidant stress in CypD KO mice. Liver content of total glutathione (GSH ϩ GSSG) (A), glutathione disulphide (GSSG) (B) and the GSSG-to-GSH ratio (C) in untreated mice or those treated with 200 mg/kg APAP for 6 h. The data represents mean Ϯ SE of n ϭ 5 animals per group. * p Ͻ 0.05 (compared to untreated controls), # p Ͻ 0.05 (compared to APAPtreated wild type mice).
of APAP [30] . In contrast, cyclosporine A effectively reduced APAP-induced cell death in vivo [28, 29] . Our data clearly indicate that CypD is involved in regulating the MPT opening and cell death after a moderate overdose of APAP in vivo . A potential reason for the more limited effi cacy of cyclosporine A in vitro might also be the exacerbated APAP-induced oxidant stress under regular cell culture conditions [38] . Thus, more detailed time-and dose-response experiments are needed to evaluate the full extent of the benefi cial effects of inhibiting CypD in APAP hepatotoxicity.
An important issue for the interpretation of the data is whether the protective effect was caused by hepatotoxicity [10, 11, 16] , the source of nitric oxide (NO) is controversial. Evidence for [44, 45] and against [15, 46, 47] a contribution of inducible nitric oxide synthase (iNOS) was provided. In addition, involvement of endothelial NOS (eNOS) [48] or neuronal NOS (nNOS) [49] has been suggested. However, given the fact that NO can freely diffuse through membranes, multiple sources can contribute to NO formation as a precursor for peroxynitrite in vivo . Given the critical role of NO for a number of physiological processes, it appears that the increase in mitochondrial superoxide rather than increased NO formation may be the driving force for peroxynitrite generation [15, 47] .
Previous data indicate that the early mitochondrial oxidant stress triggers JNK activation [47, 50] and JNK signalling was shown to be important in APAP hepatotoxicity [47, 50, 51] . It was suggested that activated JNK translocates to the mitochondria and triggers the MPT [50] . However, the fact that in and the MPT appear to be central for the cell death mechanism independent of the dose.
In summary, our data demonstrate a critical role of CypD in APAP-induced liver injury and to our knowledge is the fi rst report using a genetic model to confi rm this in vivo . The protective effect of CypD defi ciency was associated with attenuated JNK activation and reduced oxidant stress and peroxynitrite formation suggesting that these events occur at least in part downstream of the MPT. Based on these fi ndings, CypD is a promising therapeutic target to limit APAP hepatotoxicity in vivo .
CypD-defi cient mice APAP-induced JNK activation was eliminated suggests that JNK activation can occur downstream of the MPT. The reduced oxidant stress in these mice may have been the reason for the lack of activated JNK. In this respect it needs to be kept in mind that the previous reports showing robust JNK activation and a critical role of JNK in the cell death mechanism used much higher doses of APAP [47, 50, 51] . Thus, JNK signalling may be more important in the pathophysiology at higher doses, i.e. under more severe stress conditions, than used in the current experiments. This indicates that, dependent on the dose of APAP, intracellular signalling pathways may vary. Nevertheless, mitochondrial dysfunction
